These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19404206)

  • 1. Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
    Ancel D; Amiot X; Chaslin-Ferbus D; Hagege I; Garioud A; Girot R; Pol S; Grange JD
    Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):726-9. PubMed ID: 19404206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy with interferon and ribavirin for chronic hepatitis C infection in beta-thalassaemia major.
    Saffar MJ; Saffar H; Khalilian AR; Naqshvar F
    East Mediterr Health J; 2009; 15(4):785-91. PubMed ID: 20187529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.
    Wirth S; Lang T; Gehring S; Gerner P
    Hepatology; 2002 Nov; 36(5):1280-4. PubMed ID: 12395341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus interferon and ribavirin for patients with chronic hepatitis C and failure of previous interferon-alpha therapy.
    Böcher WO; Schuchmann M; Link R; Hillenbrand H; Rahman F; Sprinzl M; Mudter J; Löhr HF; Galle PR
    Liver Int; 2006 Apr; 26(3):319-25. PubMed ID: 16584394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
    Alavian SM; Tabatabaei SV
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):123-4. PubMed ID: 19959942
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimizing ribavirin dosage: a new challenge to improve treatment efficacy in genotype 1 hepatitis C patients.
    Loustaud-Ratti V; Stanke-Labesque F; Marquet P; Gagnieu MC; Maynard M; Babany G; Trépo C;
    Gastroenterol Clin Biol; 2009; 33(6-7):580-3. PubMed ID: 19481390
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluating treatment of hepatitis C for hemolytic anemia management.
    DebRoy S; Kribs-Zaleta C; Mubayi A; Cardona-Meléndez GM; Medina-Rios L; Kang M; Diaz E
    Math Biosci; 2010 Jun; 225(2):141-55. PubMed ID: 20303990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical review of the use of erythropoietin in the treatment of anaemia during therapy for chronic hepatitis C.
    Stickel F; Helbling B; Heim M; Geier A; Hirschi C; Terziroli B; Wehr K; De Gottardi A; Negro F; Gerlach T
    J Viral Hepat; 2012 Feb; 19(2):77-87. PubMed ID: 22239497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are FoxP3(+) cells involved in hyporesponsiveness to interferon/ribavirin therapy in chronic hepatitis C?
    Westin J; Hellstrand K; Dhillon AP; Lagging M;
    J Viral Hepat; 2011 Feb; 18(2):149-51. PubMed ID: 20196808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low glomerular filtration rate is a risk factor for ribavirin-associated anaemia in old patients with chronic hepatitis C.
    Borroni G; Cazzaniga M; Andreoletti M; Ceriani R; Guerzoni P; Omazzi B; Pich MG; Prada A; Spinzi G; Terreni N; Salerno F
    J Viral Hepat; 2013 Apr; 20(4):e90-5. PubMed ID: 23490395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can angiogenesis be a target of treatment for ribavirin associated hemolytic anemia?
    Yonem O; Arslan S; Sokmensuer C; Salmanzade S
    Hepatogastroenterology; 2010; 57(99-100):562-6. PubMed ID: 20698227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New triple therapy in chronic hepatitis C. Increased patient chances].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent hepatitis C genotype 1b following liver transplantation: treatment with combination interferon-ribavirin therapy.
    Berenguer M; Prieto M; Palau A; Carrasco D; Rayón JM; Calvo F; Berenguer J
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1207-12. PubMed ID: 15489583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
    Iyoda K; Kato M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
    [No Abstract]   [Full Text] [Related]  

  • 17. [Chronic hepatitis C].
    Kumada H
    Nihon Rinsho; 2002 Jan; 60(1):182-8. PubMed ID: 11808332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The burden of HCV treatment in patients with inherited bleeding disorders.
    Fransen van de Putte DE; Fischer K; Posthouwer D; Mauser-Bunschoten EP
    Haemophilia; 2011 Sep; 17(5):791-9. PubMed ID: 21689211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
    Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
    Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic Hepatitis C in Thalassemia major patients.
    Sajjad SF; Ahmad W; Hussain Jaffery SS; Asif M; Alam SE
    J Pak Med Assoc; 2017 Jun; 67(6):926-928. PubMed ID: 28585595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.